Convergent ferroptosis and pyroptosis in MASLD-associated cardiac remodeling
Translational Research · 2026-12 · 298 · 120-131
DOI: 10.1016/j.trsl.2026.10.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Research, 2026-12. Verfasst von Huayang Gui und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, No. 33 Xidazhi Street, Nangang District, Harbin, Heilongjiang, …. Hauptthemen laut MEDLINE: Ferroptosis, Pyroptosis, Ventricular Remodeling. Die Arbeit nennt 102 Literaturangaben.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects ∼30% of the global population and is associated with increased risks of heart failure (particularly heart failure with preserved ejection fraction), atrial fibrillation, and cardiovascular mortality. Despite well-established epidemiological links between MASLD and cardiovascular disease, the molecular pathways driving MASLD-related cardiac remodeling remain incompletely understood. This state-of-the-art mini review examines ferroptosis and pyroptosis as potentially convergent regulated cell-death pathways relevant to both the steatotic liver and the remodeling heart. Ferroptosis is an iron-dependent, lipid peroxidation-driven cell death that mediates hepatocyte injury in experimental MASLD and contributes to cardiomyocyte injury under cardiac stress. Pyroptosis is an inflammasome-mediated pro-inflammatory cell death executed by gasdermin D, which amplifies tissue inflammation in hepatic and cardiac disease. Direct preclinical evidence from a pressure-overload heart-failure model demonstrates ferroptosis-to-pyroptosis signaling through the ACSL4/ALOX12/12-HETE/NLRP3 axis; however, this cascade has not yet been directly validated in MASLD models or in patients with MASLD-associated cardiac remodeling. We therefore distinguish experimentally established within-organ mechanisms from hypothesized interorgan liver-heart links, highlight shared regulators including reactive oxygen species, the cGAS/STING pathway, and the NRF2 hub, and discuss translational strategies and evidence gaps that should guide future validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, No. 33 Xidazhi Street, Nangang District, Harbin, Heilongjiang, 150006, PR China.
- Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, No. 33 Xidazhi Street, Nangang District, Harbin, Heilongjiang, 150006, PR China. Electronic address: zhangyl_2013@sina.com.
Zitieren
APA
Gui, H., Yuan, X., & Zhang, Y. (2026). Convergent ferroptosis and pyroptosis in MASLD-associated cardiac remodeling. Translational Research, 298, 120-131. https://doi.org/10.1016/j.trsl.2026.10.007
Vancouver
Gui H, Yuan X, Zhang Y. Convergent ferroptosis and pyroptosis in MASLD-associated cardiac remodeling. Translational Research. 2026;298:120-131. doi:10.1016/j.trsl.2026.10.007
BibTeX
@article{Gui2026,
author = {Gui, Huayang and Yuan, Xingxing and Zhang, Yali},
title = {Convergent ferroptosis and pyroptosis in MASLD-associated cardiac remodeling},
journal = {Translational Research},
year = {2026},
volume = {298},
pages = {120--131},
doi = {10.1016/j.trsl.2026.10.007}
}
EUVIMED